Market Share of Global Bladder Cancer Therapeutics and Diagnostics Industry
The bladder cancer and therapeutics and diagnostics market is moderately competitive and consists of several major players. The major companies active in the market are AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly, GlaxoSmithKline, F. Hoffmann-La Roche Ltd, Novartis, and Pfizer. The companies present in the market are focusing on product innovations, expansions, finding new markets, or innovating their core competencies, in order to expand their market shares.
Bladder Cancer Therapeutics & Diagnostics Market Leaders
Bristol-Myers Squibb Company
GlaxoSmithKline PLC
Johnson & Johnson (Janssen Pharmaceutical)
F. Hoffmann-La Roche
Merck & Co. Inc.
*Disclaimer: Major Players sorted in no particular order
